These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7656625)

  • 41. Physician perceptions and management of COPD.
    Kesten S; Chapman KR
    Chest; 1993 Jul; 104(1):254-8. PubMed ID: 8325079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?
    Adesanoye DT; Willey CJ
    Ann Pharmacother; 2017 Oct; 51(10):855-861. PubMed ID: 28573879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of chronic obstructive pulmonary disease in elderly Finns.
    Isoaho R; Puolijoki H; Huhti E; Kivelä SL; Laippala P; Tala E
    Respir Med; 1994 Sep; 88(8):571-80. PubMed ID: 7991881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High resolution CT and bronchial reversibility test for diagnosing COPD.
    Kurashima K; Takayanagi N; Sato N; Kanauchi T; Hoshi T; Tokunaga D; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M
    Respirology; 2005 Jun; 10(3):316-22. PubMed ID: 15955144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction.
    Berger R; Smith D
    Chest; 1988 Mar; 93(3):541-6. PubMed ID: 3223980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.
    Cukier A; Ferreira CA; Stelmach R; Ribeiro M; Cortopassi F; Calverley PM
    Respir Med; 2007 Apr; 101(4):746-53. PubMed ID: 17000096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use.
    Johnson J; Johnson SR
    Thorax; 2019 Oct; 74(10):999-1002. PubMed ID: 31363020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative spirometry and perioperative drug therapy in patients with obstructive pulmonary dysfunction.
    Takiguchi H; Niimi K; Tomomatsu H; Tomomatsu K; Hayama N; Oguma T; Aoki T; Urano T; Asai S; Miyachi H; Abe T; Asano K
    Tokai J Exp Clin Med; 2014 Sep; 39(3):151-7. PubMed ID: 25248432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of salmeterol in stable COPD.
    Kaushik ML; Kashyap S; Bansal SK; Sharma A
    Indian J Chest Dis Allied Sci; 1999; 41(4):207-12. PubMed ID: 10661008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
    Burdet L; de Muralt B; Schutz Y; Fitting JW
    Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
    Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
    Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
    Mitsiki E; Bania E; Varounis C; Gourgoulianis KI; Alexopoulos EC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1371-82. PubMed ID: 26229456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of bronchodilator use on the prevalence of COPD in population-based samples.
    Pérez-Padilla R; Hallal PC; Vázquez-García JC; Muiño A; Máquez M; López MV; de Oca MM; Tálamo C; Valdivia G; Pertuzé J; Jardim J; Menezes AM;
    COPD; 2007 Jun; 4(2):113-20. PubMed ID: 17530504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of transfer factor to detect different bronchodilator responses in patients with chronic obstructive pulmonary disease.
    Izquierdo-Alonso JL; Sánchez-Hernández I; Fernández Francés J; Castelao Naval J; Carrillo Arias F; Gallardo Carrasco J
    Respiration; 1998; 65(4):282-8. PubMed ID: 9730794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bronchial responsiveness in patients with restrictive spirometry.
    Keddissi JI; Elya MK; Farooq SU; Youness HA; Jones KR; Awab A; Kinasewitz GT
    Biomed Res Int; 2013; 2013():498205. PubMed ID: 24024196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
    Anthonisen NR; Connett JE; Kiley JP; Altose MD; Bailey WC; Buist AS; Conway WA; Enright PL; Kanner RE; O'Hara P
    JAMA; 1994 Nov; 272(19):1497-505. PubMed ID: 7966841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.